A detailed history of Girard Partners Ltd. transactions in Medtronic PLC stock. As of the latest transaction made, Girard Partners Ltd. holds 4,773 shares of MDT stock, worth $370,432. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,773
Previous 5,120 6.78%
Holding current value
$370,432
Previous $421,000 1.43%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$82.84 - $88.09 $28,745 - $30,567
-347 Reduced 6.78%
4,773 $415,000
Q4 2023

Feb 09, 2024

SELL
$69.43 - $83.43 $297,090 - $356,996
-4,279 Reduced 45.53%
5,120 $421,000
Q3 2023

Nov 02, 2023

SELL
$78.22 - $90.4 $886,389 - $1.02 Million
-11,332 Reduced 54.66%
9,399 $736,000
Q2 2023

Aug 15, 2023

BUY
$79.47 - $91.38 $129,536 - $148,949
1,630 Added 8.53%
20,731 $1.83 Million
Q1 2023

May 12, 2023

BUY
$76.72 - $87.58 $533,357 - $608,856
6,952 Added 57.22%
19,101 $1.54 Million
Q4 2022

Jan 26, 2023

BUY
$76.18 - $87.74 $70,695 - $81,422
928 Added 8.27%
12,149 $0
Q3 2022

Oct 20, 2022

BUY
$80.75 - $95.31 $80,669 - $95,214
999 Added 9.77%
11,221 $906,000
Q2 2022

Jul 26, 2022

BUY
$87.4 - $113.09 $55,499 - $71,812
635 Added 6.62%
10,222 $917,000
Q1 2022

Apr 27, 2022

BUY
$100.58 - $112.38 $1,810 - $2,022
18 Added 0.19%
9,587 $1.06 Million
Q4 2021

Feb 02, 2022

BUY
$99.53 - $127.75 $78,827 - $101,178
792 Added 9.02%
9,569 $989,000
Q3 2021

Nov 01, 2021

BUY
$122.75 - $135.17 $942,351 - $1.04 Million
7,677 Added 697.91%
8,777 $1.1 Million
Q3 2021

Nov 01, 2021

SELL
$122.75 - $135.17 $955,977 - $1.05 Million
-7,788 Reduced 87.62%
1,100 $1.1 Million
Q2 2021

Aug 10, 2021

SELL
$118.19 - $131.5 $108,852 - $121,111
-921 Reduced 9.39%
8,888 $1.1 Million
Q1 2021

May 06, 2021

SELL
$111.18 - $119.74 $24,237 - $26,103
-218 Reduced 2.17%
9,809 $1.16 Million
Q4 2020

Feb 02, 2021

SELL
$100.57 - $117.14 $92,524 - $107,768
-920 Reduced 8.4%
10,027 $1.17 Million
Q3 2020

Nov 13, 2020

BUY
$90.13 - $108.78 $991 - $1,196
11 Added 0.1%
10,947 $1.14 Million
Q2 2020

Aug 10, 2020

SELL
$84.11 - $103.33 $31,120 - $38,232
-370 Reduced 3.27%
10,936 $1 Million
Q1 2020

May 01, 2020

BUY
$72.92 - $121.3 $31,501 - $52,401
432 Added 3.97%
11,306 $1.02 Million
Q4 2019

Feb 03, 2020

BUY
$104.49 - $114.54 $152,868 - $167,572
1,463 Added 15.55%
10,874 $1.23 Million
Q3 2019

Nov 01, 2019

BUY
$98.02 - $111.18 $58,419 - $66,263
596 Added 6.76%
9,411 $1.02 Million
Q2 2019

Aug 12, 2019

BUY
$84.15 - $99.38 $71,695 - $84,671
852 Added 10.7%
8,815 $858,000
Q1 2019

May 08, 2019

BUY
$82.45 - $93.79 $267,385 - $304,160
3,243 Added 68.71%
7,963 $725,000
Q4 2018

Feb 11, 2019

BUY
$85.8 - $99.49 $150,836 - $174,903
1,758 Added 59.35%
4,720 $429,000
Q3 2018

Nov 09, 2018

BUY
$85.91 - $99.17 $32,388 - $37,387
377 Added 14.58%
2,962 $291,000
Q2 2018

Aug 07, 2018

BUY
$77.48 - $87.83 $200,285 - $227,040
2,585 New
2,585 $221,000
Q1 2018

Apr 18, 2018

SELL
$76.55 - $87.26 $202,015 - $230,279
-2,639 Closed
0 $0
Q4 2017

Feb 07, 2018

SELL
$76.93 - $83.5 $4,923 - $5,344
-64 Reduced 2.37%
2,639 $213,000
Q3 2017

Nov 08, 2017

SELL
$77.71 - $84.6 $9,713 - $10,575
-125 Reduced 4.42%
2,703 $210,000
Q2 2017

Aug 08, 2017

BUY
N/A
2,828
2,828 $251,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $103B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.